The Peptide Conversation Has Grown Up
A few years ago, discussing research peptides outside of bodybuilding forums was unusual. Now they are part of mainstream biohacking conversations, recommended by longevity physicians, and subject to increasing regulatory scrutiny.
BPC-157 remains the most discussed peptide in wellness circles, but it is far from the only one with a research profile worth examining. This post covers the broader landscape: what different peptides are studied for, what the evidence actually says, and what you should understand before experimenting.
Most research peptides are not FDA-approved for human use. They exist in a regulatory gray area. This post is informational only — it is not a recommendation to self-administer any compound. Discuss any peptide use with a licensed medical professional.
Related: Want to put this into practice? Try our Supplement Stack Audit to get started, and check out BPC-157 Returns: 2026 Compounding Policy Change for more context.
BPC-157: The Reference Point
Body Protection Compound 157 is a 15-amino-acid peptide derived from a protective protein found in gastric juice. It has an extensive animal study profile showing effects on tissue repair, tendon healing, gut lining integrity, and inflammation modulation.
What the evidence supports (in animals):
- Accelerated healing of tendons, ligaments, and muscles
- Gut lining repair and reduced intestinal permeability
- Reduced inflammation at injury sites
- Potential neuroprotective effects
What the evidence does not yet support:
- Anything in controlled human trials. All BPC-157 human evidence is anecdotal.
The mechanism involves upregulating growth hormone receptor expression at injury sites and modulating nitric oxide pathways. The effects are localized rather than systemic — which is both a strength (fewer systemic side effects) and a limitation (you need to get it near the target).
TB-500 (Thymosin Beta-4 Fragment)
TB-500 is a synthetic version of a peptide fragment from thymosin beta-4, a naturally occurring peptide involved in cellular repair and inflammation regulation. It is often stacked with BPC-157 in self-experimenter communities.
Studied effects (mostly animal and cell studies):
- Promotes actin polymerization, which is fundamental to cell migration during wound healing
- May reduce scar tissue formation during healing
- Anti-inflammatory properties at injury sites
- Some evidence for cardiac tissue protection after ischemic events
TB-500 and BPC-157 are often described as complementary: BPC-157 works more locally at the injury site and influences angiogenesis (new blood vessel formation), while TB-500 promotes the migration of repair cells to the injury location. Whether this theoretical synergy translates to meaningfully better outcomes is unproven in humans.
Regulatory status: TB-500 is banned in sports by WADA. It is not approved for human therapeutic use in the US.
Epithalon (Epitalon)
Epithalon is a tetrapeptide studied primarily in the context of longevity and cellular aging. The research is more robust than most peptides in the wellness community — largely because it originated from the Pavlov Institute of Gerontology in St. Petersburg, where it was studied over decades.
Studied effects:
- Telomerase activation, with demonstrated lengthening of telomeres in cell studies and some animal studies
- Regulation of melatonin production and circadian rhythm normalization
- Antioxidant effects in aging tissue
Evidence quality: Better than most peptides, with some human observational studies from Russian research, though not replicated in large Western RCTs.
What this means practically: The longevity mechanism is biologically plausible and has more research depth than most compounds in this space. The evidence is not strong enough to make confident predictions about human longevity outcomes.
Selank and Semax — Cognitive and Anxiety Applications
These two peptides developed in Russia have accumulated a more substantial research base than most compounds in this category.
Selank
A synthetic analogue of tuftsin, Selank has been studied for anxiolytic (anti-anxiety) effects. Russian clinical trials suggest effects comparable to benzodiazepines for anxiety reduction but without the sedation, tolerance, or dependence profile.
Mechanism: Modulates GABAergic and serotonergic signaling. Does not appear to cause receptor downregulation at studied doses.
Semax
Semax is an ACTH-derived peptide with nootropic and neuroprotective properties studied in clinical settings for stroke recovery and cognitive enhancement. Russian research includes trials in hospital settings for acute neurological injury.
Studied effects: Improved BDNF expression, improved cognitive performance on standardized tests, neuroprotection in ischemic conditions.
Pros
- +More research depth than most biohacker-discussed peptides
- +Both have apparent anxiolytic or cognitive benefits in clinical studies
- +Mechanism of action is clearer than for many natural nootropics
- +Non-addictive profile in available research
Cons
- -Most research is from Russian institutions — less replication in Western trials
- -Not approved for human use in the US or EU
- -Intranasal administration required for most studied forms
- -Supply chain and quality control issues are significant concerns
GHK-Cu — Skin and Tissue Repair
Copper peptide GHK-Cu (glycyl-L-histidyl-L-lysine copper) naturally declines with age. It has the most developed topical application evidence of any peptide discussed here.
Studied effects (topical):
- Wound healing acceleration
- Collagen and elastin synthesis stimulation
- Anti-inflammatory effects on skin
- Possible hair growth support
Evidence quality: Multiple peer-reviewed studies on topical application for wound healing and skin aging. The systemic (injectable) use is far less studied.
This is notable because it is the one peptide on this list with a viable over-the-counter application: topical copper peptide serums are legal, widely available, and have legitimate research support for skin health.
How to Track Peptide Experiments
Be the first to try Prova
We're building an app to track whether peptide tracking actually works. Join the waitlist.
If you are experimenting with any peptide under medical supervision, structured tracking is essential for two reasons. First, the evidence base is too thin to make confident predictions — your personal data is your only real guide. Second, placebo effects in self-experimenter communities are substantial. Without a baseline and consistent measurement, it is nearly impossible to distinguish real effects from expectation.
Track the specific outcome you are targeting: for BPC-157 or TB-500, that means documenting injury pain scores, range of motion, and recovery time milestones. For cognitive peptides, track standardized measures like reaction time, sleep quality, and subjective mental clarity ratings.
The Bottom Line
The peptide landscape extends well beyond BPC-157. Some compounds have more research depth than their mainstream obscurity would suggest — particularly Selank, Semax, and Epithalon. Others, like TB-500, have plausible mechanisms but thin human evidence. GHK-Cu stands out as the one peptide with legitimate topical applications backed by solid research and no regulatory barriers.
Approach any peptide use as a structured experiment, not a guaranteed intervention, and do it in consultation with a qualified medical provider.